Populära just nu
Ahead of CapMan's Q1 report on 3 May, our SOTP-based fair value range of EUR 2.
Positive order intake momentum Outdoor demand rebound during Q3e '24e-'26e EBIT up 3-2% Positive mo...
Q1e sales SEK 43m, down 2% y-o-y, adj. EBIT SEK 0m (0m) Tough comps due to Duni product-launch inven...
Redeye in this research piece comments Acconeer's big design win of SEK 330m.
Sales +7% and EBIT +11% vs. ABGSCe Organic growth of +10%, better than ABGSCe +3% Order bookings bea...
Redeye reinforces its view of Vertiseit following a solid Q1 report, with slightly higher ARR growth...
Redeye hosts Circio's webcast in which CEO, Dr Erik Digman Wiklund, provides an overview of the late...
Ahead of NoHo Partners' Q1 report, we leave our estimates largely intact.
Cereno Scientific has taken a step closer to advancing its second asset, CS014, a novel HDAC inhibit...
DT reports Q1 results on Apr 25. Q1 may have been a bit muted, but growth is likely to pick up pace ...
A leading consolidator in a steadily growing, fragmented market Capital-light growth, margin expansi...
Atria is currently ramping up its EUR 160m poultry investment in Finland.
Redeye comments on the positive results from a proof-of-concept study with the veterinary candidate ...
Redeye comments today's news about the collaboration with MedHelp Care, which operates one of the mo...
The main focus on the report will be on the progress regarding the start of production for Hella and...